Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors
- PMID: 24977009
- PMCID: PMC4073404
- DOI: 10.3978/j.issn.2072-1439.2014.03.38
Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors
Abstract
Background: Breast cancer stem cells (BCSCs) can be enriched by culturing of cells in non-adherent non-differentiating conditions. However, culturing mammospheres from primary breast tumors are costly and difficult to control. In order to overcome problems associated with using primary human tissues, continuous breast cancer cell lines have been developed from various sources.
Methods: In this study, a luminal subtype breast cancer cell line MCF-7 and a basal subtype cell line MDA-MB-231 were chosen. We explored the optimal culturing system for BCSCs from the two cell lines and primary breast tumors. Then, mammosphere formation efficiency (MFE), CD44(+)/CD24(-/low)ESA(+)Lin(-) cell proportion in mammospheres, and tumorigenecity of mammospheres generated from the two breast cancer cell lines and primary breast tumors were compared.
Results: Enzymatic digestion of 60 mins and the addition of B27 to the culture medium were optimal for mammosphere culturing. Mammospheres could be formed in all the three cells, in which MCF-7 had the highest MFE. After 3 weeks culture, CD44(+)/CD24(-/low)ESA(+)Lin(-) cell proportion in mammospheres from MCF-7, MDA-MB-231 cells and primary breast tumors was 95.0%±2.5%, 82%±22% and 21.5%±1.0%, respectively. A total of 1,000 cells from MCF-7, MDA-MB-231 mammospheres but not primary mammospheres were tumorigenic.
Conclusions: This study validates the use of breast cancer cell lines as models to elucidate the nature of BCSCs.
Keywords: Breast cancer stem cells (BCSCs); MCF-7; MDA-MB-231; flow cytometry; mammosphere; primary breast tumor; tumorigenicity.
Figures




Similar articles
-
[Influence factors on the formation of mammospheres from breast cancer stem cells].Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Oct 18;40(5):500-4. Beijing Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 18931713 Chinese.
-
Characterization of the stemness potency of mammospheres isolated from the breast cancer cell lines.Tumour Biol. 2019 Aug;41(8):1010428319869101. doi: 10.1177/1010428319869101. Tumour Biol. 2019. PMID: 31423948
-
Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line.J Egypt Natl Canc Inst. 2022 Dec 12;34(1):51. doi: 10.1186/s43046-022-00152-1. J Egypt Natl Canc Inst. 2022. PMID: 36504339
-
Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.Phytomedicine. 2019 May;58:152740. doi: 10.1016/j.phymed.2018.11.001. Epub 2018 Nov 12. Phytomedicine. 2019. PMID: 31005718
-
Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells.Clin Transl Oncol. 2020 Sep;22(9):1619-1634. doi: 10.1007/s12094-020-02307-9. Epub 2020 Feb 13. Clin Transl Oncol. 2020. PMID: 32056127
Cited by
-
A reliable parameter to standardize the scoring of stem cell spheres.PLoS One. 2015 May 14;10(5):e0127348. doi: 10.1371/journal.pone.0127348. eCollection 2015. PLoS One. 2015. PMID: 25973895 Free PMC article.
-
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer.J Exp Clin Cancer Res. 2025 Jan 20;44(1):19. doi: 10.1186/s13046-025-03276-z. J Exp Clin Cancer Res. 2025. PMID: 39833955 Free PMC article.
-
Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics.Adv Sci (Weinh). 2024 Jun;11(24):e2308945. doi: 10.1002/advs.202308945. Epub 2024 Apr 16. Adv Sci (Weinh). 2024. PMID: 38627980 Free PMC article.
-
Blockade of Rho-associated protein kinase (ROCK) inhibits the contractility and invasion potential of cancer stem like cells.Oncotarget. 2017 Mar 28;8(13):21418-21428. doi: 10.18632/oncotarget.15248. Oncotarget. 2017. PMID: 28199964 Free PMC article.
-
Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients.Cancer Cell Int. 2022 Dec 31;22(1):423. doi: 10.1186/s12935-022-02841-2. Cancer Cell Int. 2022. PMID: 36585652 Free PMC article.
References
-
- Schulenburg A, Ulrich-Pur H, Thurnher D, et al. Neoplastic stem cells: a novel therapeutic target in clinical oncology. Cancer 2006;107:2512-20 - PubMed
-
- Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006;355:1253-61 - PubMed
-
- Li X, Lewis MT, Huang J, et al. Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy. J Natl Cancer Inst 2008;100:672-9 - PubMed
-
- Phillips TM, McBride WH, Pajonk F. The Response of CD24−/low/CD44+ Breast Cancer–Initiating Cells to Radiation. J Natl Cancer Inst 2006;98:1777-85 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous